MarketCap
Facebook
X
TelegramAnnual report 2022
added 03-31-2023
Ayala Pharmaceuticals Current Ratio 2011-2026 | AYLA
Annual Current Ratio Ayala Pharmaceuticals
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | 6.43 | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 6.43 | 6.43 | 6.43 |
Current Ratio of other stocks in the Biotechnology industry
| Issuer | Current Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
MorphoSys AG
MOR
|
1.02 | - | 2.43 % | $ 254 M |  Germany |
 |
Aclaris Therapeutics
ACRS
|
3.4 | $ 2.69 | 0.19 % | $ 208 M |  USA |
 |
Ascendis Pharma A/S
ASND
|
0.918 | $ 208.25 | -2.36 % | $ 5 B |  Danmark |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
3.59 | - | - | $ 40.3 B | USA |
 |
Alterity Therapeutics Limited
ATHE
|
7.02 | $ 3.42 | 6.54 % | $ 8.23 B |  Australia |
 |
AgeX Therapeutics
AGE
|
1.81 | - | -10.17 % | $ 12.2 K | USA |
 |
Biophytis SA
BPTS
|
1.34 | - | -13.47 % | $ 169 M |  France |
 |
Akero Therapeutics
AKRO
|
10.9 | - | - | $ 3.67 B | USA |
 |
Aeglea BioTherapeutics
AGLE
|
6.71 | - | - | $ 1.01 B | USA |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
1.02 | - | -1.52 % | $ 24.7 M | USA |
 |
Albireo Pharma
ALBO
|
2.39 | - | -0.23 % | $ 916 M | USA |
 |
Midatech Pharma plc
MTP
|
2.29 | - | -18.52 % | $ 27.3 M |  Britain |
 |
Alpine Immune Sciences
ALPN
|
2.67 | - | - | $ 2.17 B | USA |
 |
AlloVir
ALVR
|
22.6 | - | 4.14 % | $ 49.1 M | USA |
 |
Ampio Pharmaceuticals
AMPE
|
2.41 | - | -11.43 % | $ 502 K | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
2.76 | $ 4.35 | -7.64 % | $ 9.47 B |  Israel |
 |
Applied Molecular Transport
AMTI
|
2.31 | - | - | $ 10.1 M | USA |
 |
Aravive
ARAV
|
1.21 | - | -13.39 % | $ 1.45 M | USA |
 |
Arena Pharmaceuticals
ARNA
|
10.8 | - | -6.81 % | $ 3.04 B | USA |
 |
Athersys
ATHX
|
2.38 | - | 3.77 % | $ 22.4 M | USA |
 |
Avenue Therapeutics
ATXI
|
3.27 | - | -52.27 % | $ 4.45 M | USA |
 |
AIkido Pharma
AIKI
|
6.48 | - | 1.93 % | $ 17.4 M | USA |
 |
Институт стволовых клеток человека
ISKJ
|
1.04 | - | - | - |  Russia |
 |
Autolus Therapeutics plc
AUTL
|
2.2 | $ 1.91 | -2.31 % | $ 487 M | Britain |
 |
ARCA biopharma
ABIO
|
28.7 | - | 1052.0 % | $ 415 M | USA |
 |
Acasti Pharma
ACST
|
13.4 | - | 4.01 % | $ 150 M |  Canada |
 |
Adaptimmune Therapeutics plc
ADAP
|
1.16 | - | -15.15 % | $ 60.3 M | Britain |
 |
BioNTech SE
BNTX
|
7.22 | $ 98.56 | -1.52 % | $ 27.2 B | Germany |
 |
AVROBIO
AVRO
|
15.9 | - | 1083.1 % | $ 745 M | USA |
 |
Amphastar Pharmaceuticals
AMPH
|
1.87 | $ 27.72 | 1.43 % | $ 1.34 B | USA |
 |
CureVac N.V.
CVAC
|
2.47 | - | - | $ 867 M | Germany |
 |
Acer Therapeutics
ACER
|
0.41 | - | 2.71 % | $ 14 M | USA |
 |
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
0.612 | $ 11.49 | -2.21 % | $ 743 M | USA |
 |
BioDelivery Sciences International
BDSI
|
2.37 | - | -4.8 % | $ 255 M | USA |
 |
Axon Enterprise
AXON
|
2.08 | $ 611.74 | -1.48 % | $ 46.3 B | USA |
 |
Aytu BioScience
AYTU
|
1.47 | $ 2.71 | -4.24 % | $ 17 M | USA |
 |
BeiGene, Ltd.
BGNE
|
2.29 | - | 0.49 % | $ 251 B |  Cayman-islands |
 |
AstraZeneca PLC
AZN
|
1.65 | $ 94.15 | -1.06 % | $ 96.9 B | Britain |
 |
Bellicum Pharmaceuticals
BLCM
|
6.32 | - | -9.72 % | $ 5.89 M | USA |
 |
Acorda Therapeutics
ACOR
|
1.61 | - | -24.86 % | $ 820 K | USA |
 |
Brickell Biotech
BBI
|
5.28 | - | -5.38 % | $ 6.06 M | USA |
 |
BioVie
BIVI
|
8.46 | $ 1.3 | -4.07 % | $ 1.92 M | USA |
 |
Burford Capital Limited
BUR
|
2.14 | $ 9.29 | -0.05 % | $ 1.51 B | Britain |
 |
Berkeley Lights
BLI
|
2.69 | - | -7.31 % | $ 87 M | USA |
 |
Biogen
BIIB
|
2.47 | $ 185.27 | -0.88 % | $ 27 B | USA |
 |
Abeona Therapeutics
ABEO
|
1.3 | $ 5.1 | -2.39 % | $ 109 M | USA |
 |
bluebird bio
BLUE
|
1.46 | - | - | $ 546 M | USA |
 |
ADiTx Therapeutics
ADTX
|
1.35 | $ 0.84 | -0.24 % | $ 11.1 K | USA |
 |
Advaxis
ADXS
|
5.93 | - | -9.65 % | $ 45.9 M | USA |